Eli Lilly (LLY) will acquire Verve Therapeutics (VERV) for up to $13.5/share, aiming to revolutionize cholesterol treatment.

AG Mortgage Investment Trust's 9.5% Senior Notes offer a stable, high-yield income with less volatility than the common stock ...

As investors and headlines have focused on tariff policy and trade talks, Asian currencies have been strengthening.

PSL has outperformed XLP in recent years, but carries higher risk and slightly lower risk-adjusted returns, making it a ...

SPDR FTSE International Government Inflation-Protected Bond ETF offers exposure to non-US inflation-linked government bonds.

In a year of shocks, turmoil, and tariffs, investor sentiment has been whipped to and fro as the crowd struggles to assess ...

Retail sales dropped by a sharp -0.9 percent for May, even worse than the market expectation of -0.6 percent. Click to read.

B Verve Therapeutics (VERV) acquisition offers investors a 70%+ premium. See why I think this deal is beneficial to both ...

Amprius focuses on delivering SiCore battery cells from the $20 million LEV contract in H1 of 2025. Read why I downgraded my ...

Intel Corporation faces market share losses to Advanced Micro Devices, Inc. but is set for a turnaround with new products and ...

Discover why Blackstone Secured Lending (BXSL) stands out among BDCs with a 10% yield, low-risk portfolio, and steady income ...

Hyster-Yale faces ongoing challenges in 2025, yet its strong yield may appeal to investors seeking mean-reversion plays in ...